Total Payments
$1,226
2024 Payments
$27.11
Companies
6
Transactions
46
Medicare Patients
331
Medicare Billing
$94,004
Payment Breakdown by Category
Food & Beverage$1,226 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,226 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $841.60 | 34 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $132.62 | 7 | $0 (2022) |
| Allergan Inc. | $104.08 | 2 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $96.19 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $27.11 | 1 | $0 (2024) |
| Lundbeck LLC | $24.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.11 | 1 | Teva Pharmaceuticals USA, Inc. ($27.11) |
| 2022 | $196.74 | 5 | Neurocrine Biosciences, Inc. ($96.19) |
| 2021 | $234.41 | 9 | Janssen Pharmaceuticals, Inc ($211.81) |
| 2020 | $435.65 | 24 | Janssen Pharmaceuticals, Inc ($435.65) |
| 2019 | $155.71 | 2 | Janssen Pharmaceuticals, Inc ($155.71) |
| 2018 | $24.36 | 1 | Allergan Inc. ($24.36) |
| 2017 | $151.96 | 4 | Allergan Inc. ($79.72) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Central Nervous System | ||||||
| 11/09/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: CNS | ||||||
| 09/08/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $96.19 | General |
| Category: Neuropsychiatry | ||||||
| 04/27/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: CNS | ||||||
| 02/02/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: CNS | ||||||
| 01/06/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $38.43 | General |
| Category: Neuroscience | ||||||
| 12/14/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: CNS | ||||||
| 12/14/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: CNS | ||||||
| 12/08/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $36.51 | General |
| Category: Neuroscience | ||||||
| 12/08/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Neuroscience | ||||||
| 11/10/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $38.93 | General |
| Category: Neuroscience | ||||||
| 10/27/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Neuroscience | ||||||
| 09/08/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $36.55 | General |
| Category: Neuroscience | ||||||
| 08/18/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Neuroscience | ||||||
| 02/03/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $38.21 | General |
| Category: Neuroscience | ||||||
| 12/23/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Neuroscience | ||||||
| 12/09/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Neuroscience | ||||||
| 12/09/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: Neuroscience | ||||||
| 11/16/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $37.24 | General |
| Category: Neuroscience | ||||||
| 10/21/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: Neuroscience | ||||||
| 10/21/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: Neuroscience | ||||||
| 09/30/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $35.06 | General |
| Category: Neuroscience | ||||||
| 09/30/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Neuroscience | ||||||
| 09/09/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Neuroscience | ||||||
| 09/09/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 86 | 346 | $54,605 | $20,681 |
| 2022 | 2 | 81 | 380 | $59,905 | $23,590 |
| 2021 | 2 | 90 | 462 | $72,270 | $28,645 |
| 2020 | 2 | 74 | 368 | $56,435 | $21,088 |
Total Patients
331
Total Services
1,556
Medicare Billing
$94,004
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 175 | $32,375 | $11,751 | 36.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 43 | 171 | $22,230 | $8,930 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 191 | $35,335 | $13,171 | 37.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 40 | 189 | $24,570 | $10,419 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 233 | $43,105 | $16,206 | 37.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 45 | 229 | $29,165 | $12,439 | 42.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 37 | 184 | $34,040 | $10,741 | 31.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 37 | 184 | $22,395 | $10,347 | 46.2% |
About Dr. Ronald Sager, M.D
Dr. Ronald Sager, M.D is a Psychiatry healthcare provider based in Capitola, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780739706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Sager, M.D has received a total of $1,226 in payments from pharmaceutical and medical device companies, with $27.11 received in 2024. These payments were reported across 46 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,226).
As a Medicare-enrolled provider, Sager has provided services to 331 Medicare beneficiaries, totaling 1,556 services with total Medicare billing of $94,004. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Capitola, CA
- Active Since 01/23/2007
- Last Updated 10/18/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780739706
Products in Payments
- SPRAVATO (Drug) $777.78
- LATUDA (Drug) $132.62
- VRAYLAR (Drug) $104.08
- INGREZZA (Drug) $96.19
- INVEGA SUSTENNA (Drug) $63.82
- Austedo XR (Drug) $27.11
- REXULTI (Drug) $24.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.